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Abstract
Background: Dengue fever is one of the most common tropical diseases worldwide. Early detection of the
disease, followed by intravenous fluid therapy in patients with dengue hemorrhagic fever (DHF) or with warning
signs of dengue has a major impact on the prognosis. The purpose of this study is to describe the care provided
in a hydration tent, including early detection, treatment, and serial follow-up of patients with dengue fever.
Findings: The analysis included all patients treated in the hydration tent from April 8 to May 9, 2008. The tent was
set up inside the premises of the 2
nd Military Firemen Group, located in Meier, a neighborhood in Rio de Janeiro,
Brazil. The case form data were stored in a computerized database for subsequent assessment. Patients were
referred to the tent from primary care units and from secondary city and state hospitals. The routine procedure
consisted of an initial screening including vital signs (temperature, blood pressure, heart rate, and respiratory rate),
tourniquet test and blood sampling for complete blood count. Over a 31-day period, 3,393 case recordings were
seen at the hydration tent. The mean was 109 patients per day. A total of 2,102 initial visits and 1,291 return visits
were conducted. Of the patients who returned to the hydration tent for reevaluation, 850 returned once, 230
returned twice, 114 returned three times, and 97 returned four times or more. Overall, 93 (5.3%) patients with DHF
seen at the tent were transferred to a tertiary hospital. There were no deaths among these patients.
Discussion: As the epidemics were already widespread and there were no technical conditions for routine
serology, all cases of suspected dengue fever were treated as such. Implementing hydration tents decrease the
number of dengue fever hospitalizations.
Background
Dengue fever is one of the most common tropical dis-
e a s e sw o r l d w i d ea n di sc a u s e db yaFlavivirus trans-
mitted to humans by infected Aedes aegypti mosquitoes
[1]. The natural habitat of this disease comprises tropi-
cal and subtropical regions with warm and humid cli-
mates. The mosquito will reproduce in small water
collections such as in flower vases, uncovered water sto-
rage vessels, used automobile tires and any place where
clean water might be trapped; therefore, its control is
very difficult and highly dependent on the local popula-
tion’ss a n i t a r yh a b i t s[ 2 ] .D u et oi t sg e o g r a p h i c
characteristics, the city of Rio de Janeiro has long suf-
fered dengue fever outbreaks and epidemics.
Early detection of the disease, followed by intravenous
fluid therapy in patients with dengue hemorrhagic fever
(DHF) or with complicated dengue fever has a major
impact on the prognosis [1,3,4].
In 2008, in the city of Rio de Janeiro, Brazil, 232
deaths from dengue fever were officially recorded [5].
This figure exceeded the one reported during the pre-
vious epidemic of 2001, when 91 people died of the dis-
ease. In the whole State of Rio de Janeiro, 143,350 cases
were registered in the period from January 1
st to May
30
th 2008. In 2002, 288,245 cases were recorded. Chil-
dren under 15 years of age accounted for 46% of all
deaths in 2002 [6,7]. * Correspondence: alexmarra@einstein.br
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Hospital in São Paulo, Brazil, volunteered to provide
support for healthcare authorities in Rio de Janeiro by
sending a multidisciplinary team and medical supplies.
The objective was to organize and supply a hydration
tent to the victims of dengue fever. This paper contains
a description of the care provided in a hydration tent,
including early detection, treatment and transfer of the
severe cases to the hospitals.
Materials and methods
The analysis included for all patients treated in the hydra-
tion tent from April 8 to May 9, 2008. The tent was set up
inside the premises of the 2
nd Military Firemen Group,
located in Meier, a neighborhood of Rio de Janeiro, Brazil.
The case form data were stored in a computerized (an
electronic) database for subsequent assessment.
As the epidemics were already widespread and (there
were no technical conditions for) routine serology could
not be performed given the technical circumstances, all
cases of suspected dengue fever were treated as such.
This fact might have influenced the total number of
cases recorded. However, the Rio de Janeiro State
healthcare agency recommended any dengue fever case
with suggestive symptoms be considered as such. In this
context, it is not feasible to perform universal serology
testing for dengue fever in the affected population.
Characteristics of the hydration tent and the
multidisciplinary team
The tent covered an area of 1,400 sq. ft. and included a
waiting room with 20 seats, a medical office with two
tables and one stretcher, a small cool room for blood
count tests and a room for intravenous fluid replace-
ment with 30 armchairs.
The hydration tent was open and operational around
the clock. It was equipped with supplies for venipunc-
ture, intravenous solutions, an automated blood cell
analyzer (Coulter T-890, Diamond Diagnostics, US) that
released results within 40 seconds and symptomatic
medication (metamizole, paracetamol, metoclopramide,
and dimenhydrate). The multidisciplinary team con-
sisted of 197 professionals from the Albert Einstein Hos-
pital staff, in São Paulo, Brazil, including 81 nursing
assistants, 48 nurses, 51 medical doctors, 8 lab techni-
cians, and 9 administrative support employees. In each
12-hour shift, a team of 4 medical doctors (2 general
practitioners [GPs] and 2 pediatricians), 3 nurses, 6 nur-
sing assistants, 2 administrative clerks and 1 lab techni-
cian were on duty.
Patient care flow and rehydration therapy
Patients were referred to the tent from primary care
units and from secondary city and State hospitals. The
routine procedure consisted of an initial screening
including vital signs (temperature, blood pressure, heart
rate, and respiratory rate), tourniquet test and blood
sampling for complete blood count (CBC). Once
screened, the patients were seen either by a pediatrician
or by a GP and evaluated through a detailed medical
history and physical examination, besides an analysis of
the CBC report. If the clinical diagnosis of dengue fever
was confirmed, the patient was assigned to one of three
groups: A - oral rehydration therapy (ORT), B - intrave-
nous rehydration therapy (IVT), or C - discharge with
recommendations.
The dehydration status was assessed during the physi-
cal examination by the doctor or through the hemato-
crit, performed together with the CBC. We complied
with the WHO case definition of dengue hemorrhagic
fever (DHF) [3].
The decision to start ORT or IVT was taken by the
physician, based on clinical and laboratory (CBC) cri-
teria [3]. ORT consisted of encouraging fluid ingestion,
under supervision, either at the water fountains installed
in the tent or by volunteers who constantly offered the
patients filtered water. In addition, the patients received
instructions about fluid ingestion at home. IVT con-
sisted of the intravenous administration of normal saline
or 5% dextrose with electrolytes. Some of these patients
had nausea or vomiting and we prescribed intravenous
antiemetics.
After ORT or IVT, patients were reassessed and a new
CBC was performed to check the effectiveness of the
rehydration measures. If there were no signs of clinical
and laboratorial improvement, patients received another
course of intravenous fluid therapy. They were then
reassessed and, if necessary, transferred to a tertiary care
hospital. Patients showing improvement were discharged
and instructed to return if they experienced symptoms
of disease progression, such as dehydration, persistent
vomiting or diarrhea, bleeding events or signs of hemo-
dynamic instability. In addition, they received an ID
card with data on their hematocrit, platelet count and
vital signs. The patients were instructed to bring along
this card in case they returned to the tent for further
assessment. Supportive serology tests (IgM antibody test
on a late acute or convalescent-phase serum specimen)
were performed only for in-patients with DHF [1]. None
of the cases (except DHF) were confirmed by specific
laboratory tests. Patients up to 15 years of age were con-
sidered pediatric patients.
T h eD H Fc a s e sw e r eh o s p i t a l i z e d .T h e s eD H Fc a s e s
could be identified either at the first visit or in the
course of the disease. When such a case (DHF) was
identified, our team immediately triggered (mobilized) a
medical call center asking for the patient’s hospitaliza-
tion in a public hospital in Rio de Janeiro city. The data
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death) were received from the Rio de Janeiro State
healthcare agency.
Results
Over a 31-day period, 3,393 case recordings were seen
at the hydration tent in Meier, Rio de Janeiro. The
mean was 109 patients per day, with a peak of 232 visits
on April 14, 2008.
The total number of case recordings studied included
2,594 (76.5%) adults and 799 (23.5%) pediatric patients.
A total of 2,102 initial visits and 1,291 return visits
were conducted. In the 2,102 initial visits, 1,739
patients had clinical symptoms that were suggestive of
dengue fever; 363 patients did not present clinical
symptoms suggestive of dengue fever and had other
differential diagnoses. Of the 1,739 patients with clini-
cal symptoms of dengue fever, 1,320 were adults
(75.9%) and 419 were children (24.1%). Of the case
recordings that returned to the hydration tent for ree-
valuation (n = 1,291), 850 returned once, 230 returned
twice, 114 returned three times and 97 returned four
times or more (to a maximum of 8 times). A total of
363 patients (with 407 visits) did not have clinical
symptoms that were suggestive of dengue fever and
the most common differential diagnoses detected at
the Tent’s Triage are depicted in Table 1. In our analy-
sis we have considered only dengue fever cases.
The most frequent clinical symptoms suggestive of
dengue fever reported by adults at the first visit (n =
1,320) were: headache (77%), fever (70%), myalgia (69%),
retro-orbital pain (38%), abdominal pain (32%), nausea
(32%), vomiting (28%), diarrhea (23%), rash (8%), and
dyspnea (6%). In children (n = 419) the most common
symptoms were: fever (85%), headache (59%), vomiting
(42%), myalgia (38%), abdominal pain (33%), diarrhea
(19%), retro-orbital pain (18%), nausea (16%), rash
(16%), and dyspnea (3%). Only 10% of all of the cases (n
= 1,739) had a positive tourniquet test.
In adults (n = 1,320), laboratory test results showed
mean values of hematocrit, platelet count and leukocyte
count at the initial visit of 41.3 ± 8.9%, 176.0 ± 91.3
(10
3/mm
3), and 5.3 ± 3.8 (10
3/mm
3) respectively. In
children (n = 419), the mean values of hematocrit, plate-
let count and leukocyte count at the time of the initial
visit were 39.3 ± 4.1%, 211.0 ± 92.9 (10
3/mm
3), and 6.4
± 4.5 (10
3/mm
3), respectively.
As to what concerns treatment modality, 824 case
recordings (24.3%) received IVT. Of this total, 230 case
recordings (28%) required a reevaluation after the initial
intravenous fluid therapy and had a second CBC per-
formed during the same visit. IVT was used in 117 chil-
dren (27.9% of the pediatric patients, n = 419) and in
365 adults (27.7% of the adult patients, n = 1320).
In the adult population (n = 1,320), 172 patients had
platelet counts lower than 100,000/mm
3 (13.0%) and 86
also showed signs of hemoconcentration (6.5%). In the
pediatric population (n = 419), 56 patients had platelet
counts lower than 100,000/mm
3 (13.4%), and 55 also
showed signs of hemoconcentration (13.1%).
Overall, 93 (5.3%) patients with DHF seen at the tent
were transferred to a tertiary hospital. Of these, 78 were
adults (83.9%) and 15 were children (16.1%).
Despite the need for hospitalization in 5% of the cases
due to the severity of the disease, there were no deaths
among these patients. Moreover, our team avoided
potential hospitalizations in dengue fever patients. This
suggests that the initial therapeutic approach was effec-
tive. CBC reports were available for all the patients seen
at the hydration tent within 40 seconds, which allowed
immediate therapeutic decisions to be made based on
the presence or absence of hemoconcentration and
thrombocytopenia.
Discussion
During the first half of 2008, the number of notified
cases of dengue fever was overwhelming, reaching a
level similar to that of the 2002 epidemic, the worst in
the past 20 years. From January to July 2008, more than
120,000 cases were recorded at the Rio de Janeiro State
healthcare agency, while 150,321 cases had been notified
over the whole year 2002 [6,7]. These data reflected an
extremely serious public health issue in Rio de Janeiro
[8]. The massive demand for medical assistance from a
public system that already operated at its maximum
capacity resulted in long waiting lines, restricted access
to healthcare services and a shortage of hospital beds,
both in public and private sectors. This ultimately led to
chaos in the city [8,9].
Patients who could have been diagnosed and treated
at an earlier stage, using low-complexity diagnostic and
therapeutic tools, progressed to more severe forms of
the disease [10]. With the increasing number of cases,
Table 1 Most common differential diagnosis detected at
Tent’s Triage (N = 363)
Symptoms %
Upper Airway Infection 43
Gastroenterocolitis 25
Community Acquired Pneumonia 6
Bacterial Amigdalitis 6
Sinusitis 3
Migraine 3
Appendicitis 2
Rubeolla 1
Hypoglicemia 1
Other 10
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sionals soon became critical. In this context, some emer-
gency measures, such as the implementation of
hydration tents, proved to be a key factor in epidemic
control. In total, 17 hydration tents were deployed in
the State to receive patients referred by primary care
units and emergency hospitals with symptoms sugges-
tive of dengue fever. This was one of the reasons for
offering help to the city of Rio de Janeiro, and sending a
multidisciplinary team with a hydration tent in order to
lower the disease morbidity, the number of hospitaliza-
tions and if possible, the mortality rates. If any major
complication was detected, the patient was transferred
to a tertiary hospital. Over the study period, there were
no patient deaths among those treated at the Meier
hydration tent. The multidisciplinary team consisted for
professionals from various sectors of our hospital (inten-
sive care, emergency, pediatrics, surgery, etc.). All
engage in volunteer work providing care to all patients
who visited the tent of hydration.
Significantly, 25% of all the patients seen at our hydra-
tion tent could be treated with intravenous fluid therapy
on-site, thus avoiding unnecessary referral to overloaded
hospitals.
A major contribution of this approach was to demon-
strate that simple, low-cost measures were effective in
the care of patients with dengue fever during the epi-
demics in Rio de Janeiro, and had the positive impact of
possibly reducing not only patient mortality but also to
avoid the hospitalization of dengue fever patients in the
Rio de Janeiro crowded hospitals, which we believe was
our most valuable contribution.
The kind of help provided reduced the waiting lines in
the surrounding hospitals, decentralized services and
allowed earlier diagnosis and treatment of the more
severe cases. Another very positive result of this effort
was the significant growth in knowledge and experience
on the part of the multidisciplinary team. As they saw an
increasing number of patients, the healthcare team felt
more confident to make decisions and provide better
patient care, thus avoiding unnecessary hospitalizations.
The clinical and laboratory data obtained were similar
to those reported in the literature [1,11], and underline
the relevance and potential magnitude of this disease
when it is not immediately controlled. While dengue
fever is, in theory, a low-complexity and easily manage-
able disease, it has potentially devastating consequences
when there is a favorable environment for the fast pro-
liferation of the mosquito, as it happens to be the case
in Rio de Janeiro [8].
Several studies suggest different dengue vector strate-
gies in urban settings [12,13] and try to achieve dengue
control in many parts of the world [14,15]. Focus is also
on the discussion about taking care of in-hospital
dengue fever patients [16,17]. However, we did not find
any similar study providing solutions for taking care of
dengue fever patients outside hospitals.
Therefore, it is important to emphasize that the efforts
made to provide care for patients with dengue fever
during epidemics represent a major contribution to pre-
vent further complications, including death. However, if
there is no commitment to primary prevention, there
will always be a need to treat the consequences of the
disease instead of attacking its cause. A preventive atti-
tude needs to be adopted not only by government
bodies but also by the general population, who must
improve their sanitary and hygienic habits in the near
future.
Limitations
Since all the patients that were followed at the Tent were
referred from other hospitals or ambulatory clinics, they
might have been previously medicated for symptoms
such as pain, fever or nausea for example. Therefore, at
the Tent’s Triage, some patients may not have informed
correctly about all the symptoms they might be feeling
on that occasion (at the Tent’s Triage). So the percentage
of symptoms could have been underestimated.
Conclusions
Although a manageable disease, dengue fever still repre-
sents a major challenge for public health care services in
tropical countries with a favorable environment for the
Aedes aegypti. Primary prevention measures produce a
great impact on the control of epidemics such as the one
observed in 2008, and must be urgently improved. In dis-
aster situations, implementing hydration tents might
change the fatal outcome of the more severe cases. The
multidisciplinary team approach has proven to be essen-
tial for the effective management of the hydration tent.
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